|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 20/01/21 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 22/12/20 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 01/01/2020 |
Patty Meehan
ADM | Chief Administrative Officer | - | 01/01/2002 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | - | |
| Director/Board Member | 71 | 01/07/2019 | |
Kyle C. Kerbawy
CHM | Chairman | 79 | 01/08/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 340M | |
| -0.27% | -4.74% | -20.25% | +4.47% | 182B | |
| -0.54% | -0.31% | -2.32% | +14.92% | 118B | |
| -0.42% | -3.88% | +8.25% | +81.95% | 61.7B | |
| -0.62% | -5.70% | +11.32% | +43.44% | 50.55B | |
| +0.98% | -4.12% | -5.61% | -32.60% | 48.98B | |
| -0.77% | -6.48% | +6.99% | -19.62% | 31.65B | |
| -1.84% | -6.20% | - | - | 29.87B | |
| -0.24% | -1.66% | +33.69% | -14.30% | 23.71B | |
| -2.29% | -10.25% | -14.50% | +3.38% | 21.78B | |
| Average | -0.61% | -3.62% | +2.20% | +10.21% | 56.82B | |
| Weighted average by Cap. | -0.45% | -2.99% | -4.55% | +13.64% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 89.22M 76.77M 72.29M 65.87M 123M 8.49B 124M 857M 331M 4.33B 335M 328M 13.7B | 101M 86.73M 81.67M 74.41M 139M 9.59B 140M 968M 374M 4.89B 378M 370M 15.48B |
| Net income | -3.13M -2.69M -2.54M -2.31M -4.33M -298M -4.34M -30.07M -11.62M -152M -11.76M -11.5M -481M | 1.45M 1.25M 1.17M 1.07M 2M 138M 2.01M 13.91M 5.38M 70.23M 5.44M 5.32M 222M |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
